MEDIBIOFARMA SL
To make disease-modifying treatments available to patients with serious or life-threatening conditions
8 employees · est. 2016 · Spain
Nimbus Therapeutics
We develop breakthrough medicines for patients through precision small molecule design.
99 employees · est. 2009 · Boston, United States
Nimbus Therapeutics is the older company (2016 vs 2009); Nimbus Therapeutics is the larger of the two.
Side-by-Side Comparison
| Metric | MEDIBIOFARMA SL | Nimbus Therapeutics |
|---|---|---|
| Founded | ||
| Founded | 2016 | 2009 older |
| Headquarters | ||
| Headquarters | Spain | Boston, United States |
| Employees | ||
| Employees | 8 | 99 larger |
| Industry | ||
| Industry | Biotechnology, Health Care | Biotechnology, Health Care, Health and Wellness |
| Funding Stage | ||
| Funding Stage | Series Unknown | Private Equity |
| Total Funding | ||
| Total Funding | $2.42M | $637.00M |
| Funding Rounds | ||
| Funding Rounds | 5 | 9 |
| Services | ||
| Services | Not tracked yet | Target Selection, Drug Discovery, Translational Medicine, Clinical Development, Development of Small Molecule Medicines |
| Target Customers | ||
| Target Customers | Not tracked yet | Patients with Oncology Conditions, Patients with Immunological Disorders, Patients with Metabolic Indications, Biotechnology and Pharmaceutical Corporations, Healthcare Professionals |
| Taxonomy | ||
| Taxonomy | Clinical-stage, Research Programs, Drug Discovery, Therapeutic Targets, Cancer Treatment, Non-cancer Diseases, Disease-modifying Treatments, Pharmaceutical Industry, Innovation, Lifethreatening Conditions, Medibiofarma S.L, Biopharmaceutical, Medical Research | Precision Medicine, Small Molecule Design, Structure-based Drug Discovery, Computational Technologies, Machine Learning In Drug Development, Clinical-stage Therapeutics, Oncology, Immunology, Metabolic Diseases, Cancer Treatment, Autoimmune Conditions, HPK1 Inhibitor, WRN Program, Computational Chemistry |
| Website | ||
| Website | medibiofarma.com | nimbustx.com |
About MEDIBIOFARMA SL
MEDIBIOFARMA SL is a clinical-stage biotechnology company founded in 2016 by a group of professionals with extensive experience in Drug Discovery in the pharmaceutical industry. The company's slogan "To make disease-modifying treatments available to patients with serious or life-threatening conditio...
About Nimbus Therapeutics
Nimbus Therapeutics, founded in 2009, is a pioneering biotechnology company headquartered in the United States. The company is dedicated to developing breakthrough medicines through precision small molecule design, leveraging sophisticated computational technologies and machine learning-based predic...
We will tell you when either one moves
BounceWatch watches MEDIBIOFARMA SL and Nimbus Therapeutics for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at MEDIBIOFARMA SL and Nimbus Therapeutics — by email.
Frequently Asked Questions
Compare MEDIBIOFARMA SL with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at MEDIBIOFARMA SL on 12 Sep 2024, and Nimbus Therapeutics on 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
